Last checked at 
13 Jul 2023 15:25
Syncona Limited
Issue of shares pursuant to long-term incentive scheme and PDMR dealings
13 July 2023
Syncona Ltd (the "Company"), a leading healthcare company focused on creating, building and scaling a portfolio of global leaders in life science, today announces that a total of 2,477,342 new ordinary shares (representing 0.37% of the Company's existing issued ordinary shares) will be issued in satisfaction of realisations under the Company's long term incentive scheme. The new ordinary shares, when issued, will rank pari passu with the existing issued ordinary shares of the Company. In accordance with the rules of the incentive scheme, the number of ordinary shares to be issued has been calculated using the closing mid-market price on 12 July, 2023, £1.548.
In accordance with the rules of the incentive scheme, ordinary shares delivered on realisation may not be sold or transferred by the recipient for a period of one year following the realisation date.
The issue of shares include the following shares to be issued to senior members of the Syncona Investment Management Limited (SIML) leadership team:
Name | SIML Title | No. of shares to be issued |
Martin Murphy | Chair | 1,117,873 |
Chris Hollowood | Chief Executive Officer | 719,421 |
Application will be made to the Financial Conduct Authority for the shares to be admitted to the Official List, and to the London Stock Exchange for the shares to be admitted to trading and it is expected that dealings will commence in the new ordinary shares on 19 July 2023.
Following admission, the Company will have 671,806,666 ordinary shares in issue and the total number of voting rights in the Company will be 671,806,666. The Company does not hold any ordinary shares in treasury. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interests in, the Company under the FCA's Disclosure and Transparency Rules.
Notification of transactions by Persons Discharging Managerial Responsibilities ("PDMRs") are set out below.
[ENDS]
Enquiries
Syncona LtdAnnabel Clark / Fergus WittTel: +44 (0) 20 3981 7940
About Syncona
Syncona's purpose is to invest to extend and enhance human life. We do this by creating and building companies to deliver transformational treatments to patients in areas of high unmet need.
Our strategy is to create, build and scale companies around exceptional science to create a diversified portfolio of 20-25 globally leading life science businesses, across development stage, modality and therapeutic areas, for the benefit of all our stakeholders. We focus on developing treatments for patients by working in close partnership with world-class academic founders and management teams. Our balance sheet underpins our strategy enabling us to take a long-term view as we look to improve the lives of patients with no or poor treatment options, build sustainable life science companies and deliver strong risk-adjusted returns to shareholders.
Copies of this press release and other corporate information can be found on the company website at: www.synconaltd.com
1. | Details of PDMR / person closely associated with them ("PCA") | |||||
a) | Name | Martin Murphy | ||||
2. | Reason for the notification | |||||
a) | Position / status | Chair, SIML | ||||
b) | Initial notification / amendment | Initial Notification | ||||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | Syncona Limited | ||||
b) | LEI | 213800X8MBI5VQITLW60 | ||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument | Ordinary shares GG00B8P59C08 | ||||
b) | Nature of the transaction | Issue of shares pursuant to the Syncona long term incentive scheme | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information Aggregated volume Price |
N/A | ||||
e) | Date of the transaction | 13 July 2023 | ||||
f) | Place of the transaction | Outside a trading venue | ||||
g) | Currency | GBP - British Pound | ||||
1. | Details of PDMR / person closely associated with them ("PCA") | |||||
a) | Name | Chris Hollowood | ||||
2. | Reason for the notification | |||||
a) | Position / status | Chief Executive Officer, SIML | ||||
b) | Initial notification / amendment | Initial Notification | ||||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | Syncona Limited | ||||
b) | LEI | 213800X8MBI5VQITLW60 | ||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument | Ordinary shares GG00B8P59C08 | ||||
b) | Nature of the transaction | Issue of shares pursuant to the Syncona long term incentive scheme | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information Aggregated volume Price |
N/A | ||||
e) | Date of the transaction | 13 July 2023 | ||||
f) | Place of the transaction | Outside a trading venue | ||||
g) | Currency | GBP - British Pound | ||||